-
1 month ago | 
tolerance.ca | Erin Smith |Discipline Lead |La Trobe
© 2025 Tolerance.ca® Inc. All reproduction rights reserved. All information reproduced on the Web pages of www.tolerance.ca (including articles, images, photographs, and logos) is protected by intellectual property rights owned by Tolerance.ca® Inc. or, in certain cases, by its author. Any reproduction of the information for use other than personal use is prohibited.
-
1 month ago | 
tolerance.ca | Erin Smith |Discipline Lead |La Trobe
© 2025 Tolerance.ca® Inc. All reproduction rights reserved. All information reproduced on the Web pages of www.tolerance.ca (including articles, images, photographs, and logos) is protected by intellectual property rights owned by Tolerance.ca® Inc. or, in certain cases, by its author. Any reproduction of the information for use other than personal use is prohibited.
-
Jan 16, 2025 | 
jamanetwork.com | Jonathan Shaw |La Trobe |Alicia Jenkins
Diabetic Retinopathy—Another Possible Target for SGLT2 Inhibitors? Empagliflozin and the Risk of Retinopathy in Type 2 Diabetes Helen Tesfaye, PharmD, MSc; Julie M. Paik, MD, ScD, MPH; Miin Roh, MD, PhD; Phyo T. Htoo, MD, PhD; Heidi Zakoul, BA; Niklas Schmedt, DrPH; Lisette Koeneman, MD; Deborah J.
-
Jan 13, 2025 | 
latrobe.edu.au | La Trobe
Professor Nora Shields, Research Director of the University’s Olga Tennison Autism Research Centre (OTARC), said they had worked closely with the federal government to develop the strategy, with Associate Professor Josephine Barbaro (pictured) invited on the National Autism Strategy Oversight Committee.
-
Jan 13, 2025 | 
dailybulletin.com.au | Caroline Spry |La Trobe
On the outskirts of Melbourne, Australia, there is a series of large rings which rise mysteriously out of hills. These “earth rings”, located on Wurundjeri Woi-wurrung Country in the suburb of Sunbury, aren’t natural phenomena. In fact, they represent large scale feats of human endeavour. They also represent the ancient and ongoing connection Aboriginal people have to Country.
-
Jan 13, 2025 | 00004-6/abstract?rss=yes&sz=64)
jclinepi.com | Samantha P Chakraborty |La Trobe |Rheumatology Unit |Woodville South
5Health consumer representative, ALEC Consumer Advisory and Working Group member 6Centre for Health Communication and Participation, Department of Public Health, La Trobe University Melbourne, Australia 7Covidence.org, Melbourne, Victoria, 3000, Australia 8Centre for Health Communication and Participation, Department of Public Health, La Trobe University Melbourne, Australia 9Australian Institute of Health Innovation, Macquarie University, Sydney, Australia 10The Daffodil Centre, The...
-
Jan 11, 2025 | 
ebn.bmj.com | Catherine A Bent |Patrick Dwyer |Kristelle Hudry |La Trobe
Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways. Child HealthEvidence-Based NursingCommentary on: Sandbank M, Pustejovsky JE, Bottema-Beutel K, et al.
-
Jan 10, 2025 | 
latrobe.edu.au | La Trobe
More than 1400 hard-working students received offers from La Trobe today as part of VTAC's January first-round offers. This brings the total number of offers from the University, including November and December rounds, to 6683. La Trobe has increased its VTAC offers for the third consecutive year between the period of November to January. In addition, the University has made more than 4000 offers to direct applicants.
-
Jan 8, 2025 | 
tolerance.ca | Charles Y. Feigin |La Trobe
© 2025 Tolerance.ca® Inc. All reproduction rights reserved. All information reproduced on the Web pages of www.tolerance.ca (including articles, images, photographs, and logos) is protected by intellectual property rights owned by Tolerance.ca® Inc. or, in certain cases, by its author. Any reproduction of the information for use other than personal use is prohibited.
-
Jan 8, 2025 | 
jbiomedsci.biomedcentral.com | La Trobe
Many tumour-promoting factors derived from CAFs have been identified in the past, positioning them as promising targets for therapeutic interventions. These factors can either directly interact with cancer cells to regulate tumour actions, or affect other stromal components like immune cells. Many clinical trials have been carried out to assess the efficacy of drugs targeting these CAF-derived factors (Fig. 4; Table 4). Drugs targeting CAF-derived factors that promote tumour development.
